Prostatis Group’s Vanguard S&P Small-Cap 600 ETF VIOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,277
Closed -$261K 203
2026
Q1
$261K Sell
2,277
-772
-25% -$90.5K 0.07% 152
2025
Q4
$338K Sell
3,049
-27
-0.9% -$3K 0.08% 125
2025
Q3
$340K Buy
3,076
+170
+6% +$18.1K 0.09% 116
2025
Q2
$294K Buy
+2,906
New +$278K 0.08% 120
2024
Q3
Sell
-8,017
Closed -$787K 154
2024
Q2
$787K Buy
8,017
+7
+0.1% +$688 0.28% 74
2024
Q1
$813K Buy
+8,010
New +$779K 0.31% 73

Other funds holding VIOO

Prostatis Group's VIOO Position: Q2 2026 in Review

Prostatis Group sold out of Vanguard S&P Small-Cap 600 ETF (VIOO) in Q2 2026, closing a stake of 2,277 shares — an estimated $261K sold.

Prostatis Group first reported a position in VIOO in Q1 2024 and held it in 6 quarters. The position peaked at $813K in Q1 2024. 407 funds tracked by Wall St. Rank hold VIOO as of Q2 2026.

  • Prostatis Group reported no remaining Vanguard S&P Small-Cap 600 ETF position as of Q2 2026 after selling out during the quarter.
  • Prostatis Group sold 2,277 Vanguard S&P Small-Cap 600 ETF shares in Q2 2026, an estimated $261K.
  • Prostatis Group first reported a position in Vanguard S&P Small-Cap 600 ETF in Q1 2024 and held it in 6 quarters.
  • Prostatis Group's Vanguard S&P Small-Cap 600 ETF position peaked at $813K in Q1 2024.
  • 407 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.